CNBC April 10, 2023
Key Points
– More than 200 pharmaceutical executives signed on to an open letter calling for the reversal of a federal judge’s decision to suspend the Food and Drug Administration’s approval of the abortion pill mifepristone.
– Pfizer CEO Albert Bourla was among the corporate leaders who signed the letter after U.S. Judge Matthew Kacsmaryk’s controversial ruling Friday.
– The executives expressed support for the FDA’s authority to regulate drugs and said Kacsmaryk’s decision “ignores decades of scientific evidence and legal precedent.”
More than 200 pharmaceutical executives signed on to an open letter calling for the reversal of a federal judge’s decision to suspend the Food and Drug Administration’s approval of the abortion pill mifepristone.
Albert Bourla, the CEO...
Today's Sponsors
Today's Sponsor